Thomas F. Eleveld

Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations

Thomas F. Eleveld, Derek A. Oldridge, Virginie Bernard et al. · Nature Genetics · 2015 · 555 citations · Full text

Medicine, Cancer Biology, Oncology +9

RAS–MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in Neuroblastoma

Thomas F. Eleveld, Linda Schild, Jan Köster et al. · Cancer Research · 2018 · 58 citations · Full text

Medicine, Genetics, Oncology +17

Engineering large-scale chromosomal deletions by CRISPR-Cas9

Thomas F. Eleveld, Chaimaa Bakali, Paul P. Eijk et al. · Nucleic Acids Research · 2021 · 38 citations · Full text

Life Sciences, Genetics, Oncology +16

The Role of TP53 in Cisplatin Resistance in Mediastinal and Testicular Germ Cell Tumors

Dennis M. Timmerman, Thomas F. Eleveld, Ad Gillis et al. · International Journal of Molecular Sciences · 2021 · 30 citations · Full text

Medicine, Molecular Biology, Oncology +14

Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell Tumors

Dennis M. Timmerman, Thomas F. Eleveld, Sruthi Sriram et al. · Journal of Clinical Oncology · 2022 · 29 citations · Full text

Medicine, Genetics, Oncology +17